Trials / Completed
CompletedNCT00738842
Uric Acid Study in Healthy Male Volunteers
A Randomised, Double-Blind, Two-Period Crossover Study to Assess the Effect of AZD6140 on Uric Acid Levels in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study is being conducted to examine the effect of AZD6140 on the levels of certain chemicals in subjects' blood and urine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AZD6140 | Oral tablets taken bid for 5 days |
| DRUG | Placebo to match AZD6140 | Oral tablets taken bid for 5 days |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2008-07-01
- Completion
- 2008-07-01
- First posted
- 2008-08-21
- Last updated
- 2010-12-03
Source: ClinicalTrials.gov record NCT00738842. Inclusion in this directory is not an endorsement.